278 related articles for article (PubMed ID: 2476887)
1. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
[TBL] [Abstract][Full Text] [Related]
2. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
3. Different gradients for neurotransmitter metabolites and protein in horse cerebrospinal fluid.
Vaughn DM; Smyth GB
Vet Res Commun; 1989; 13(6):413-9. PubMed ID: 2483597
[TBL] [Abstract][Full Text] [Related]
4. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cerebrospinal fluid monoamine metabolite levels in dominant-aggressive and non-aggressive dogs.
Reisner IR; Mann JJ; Stanley M; Huang YY; Houpt KA
Brain Res; 1996 Apr; 714(1-2):57-64. PubMed ID: 8861609
[TBL] [Abstract][Full Text] [Related]
6. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
Janssens J; Atmosoerodjo SD; Vermeiren Y; Absalom AR; den Daas I; De Deyn PP
Neurochem Int; 2019 Sep; 128():154-162. PubMed ID: 31034914
[TBL] [Abstract][Full Text] [Related]
7. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
8. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
10. CSF monoamine metabolites in patients and controls: support for a bimodal distribution in major affective disorders.
Westenberg HG; Verhoeven WM
Acta Psychiatr Scand; 1988 Nov; 78(5):541-9. PubMed ID: 2466394
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
Mignot E; Laude D; Elghozi JL
J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
[TBL] [Abstract][Full Text] [Related]
12. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
Blennow K; Wallin A; Gottfries CG; Månsson JE; Svennerholm L
J Neural Transm Park Dis Dement Sect; 1993; 5(1):5-15. PubMed ID: 7679905
[TBL] [Abstract][Full Text] [Related]
13. A rostrocaudal gradient for neurotransmitter metabolites and a caudorostral gradient for protein in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Whitmer B; Satjawatcharaphong C
Am J Vet Res; 1988 Dec; 49(12):2134-7. PubMed ID: 2467594
[TBL] [Abstract][Full Text] [Related]
14. CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys.
Higley JD; Suomi SJ; Linnoila M
Psychopharmacology (Berl); 1991; 103(4):551-6. PubMed ID: 1712115
[TBL] [Abstract][Full Text] [Related]
15. Monoamine metabolites in the CSF of conscious unrestrained cats.
Degrell I; Zenner K; Kummer P; Stock G
Brain Res; 1983 Oct; 277(2):283-7. PubMed ID: 6196083
[TBL] [Abstract][Full Text] [Related]
16. Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.
Salomon RM; Kennedy JS; Johnson BW; Urbano Blackford J; Schmidt DE; Kwentus J; Gwirtsman HE; Gouda JF; Shiavi RG
Neuropsychopharmacology; 2005 Nov; 30(11):2082-91. PubMed ID: 15856079
[TBL] [Abstract][Full Text] [Related]
17. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
[TBL] [Abstract][Full Text] [Related]
18. Monoamine neurotransmitters and their metabolites in the mature rabbit brain following induction of hydrocephalus.
Del Bigio MR; Bruni JE; Vriend JP
Neurochem Res; 1998 Nov; 23(11):1379-86. PubMed ID: 9814548
[TBL] [Abstract][Full Text] [Related]
19. In-use stability of monoamine metabolites in human cerebrospinal fluid.
Strawn JR; Ekhator NN; Geracioti TD
J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):301-6. PubMed ID: 11530989
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.
Blennow K; Wallin A; Gottfries CG; Karlsson I; Månsson JE; Skoog I; Wikkelsö C; Svennerholm L
Eur Neuropsychopharmacol; 1993 Mar; 3(1):55-61. PubMed ID: 7682460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
